PNC Managed Account Solutions’s Gilead Sciences GILD Stock Holding History

PNC Managed Account Solutions’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$156K	Buy	+2,266	New	+$151K	0.03%	241

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PNC Managed Account Solutions's GILD Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Gilead Sciences (GILD) in Q2 2021: 2,266 shares worth $156K. The stake represents 0.03% of the portfolio and ranks #241 among its holdings.

1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

PNC Managed Account Solutions held 2,266 shares of Gilead Sciences worth $156K as of Q2 2021.
Gilead Sciences was a new PNC Managed Account Solutions position in Q2 2021.
Gilead Sciences made up 0.03% of PNC Managed Account Solutions's portfolio in Q2 2021, its #241 holding.
1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.